Showing results (331-340 of 571) with videos related to

Sort By:
Pageof 58
Brain : a Journal of Neurology|June 16, 2001
The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UKU Nath, Y Ben-Shlomo, R G Thomson, et al.
Acta Gastro-Enterologica Belgica|September 1, 1995
The genetic background of familial adenomatous polyposis. Linkage analysis, the APC gene identification and mutation screeningA Kartheuser, S West, C Walon, et al.
International Journal of Geriatric Psychiatry|August 15, 2006
Orthostatic hypotension in Parkinson's disease: association with cognitive decline?Liesl M Allcock, Rose Anne Kenny, Urs Peter Mosimann, et al.
Molecular Immunology|March 21, 2007
The decay accelerating factor mutation I197V found in hemolytic uraemic syndrome does not impair complement regulationD Kavanagh, R Burgess, D Spitzer, et al.
Molecular Immunology|August 3, 2006
Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndromeAnna Richards, M Kathryn Liszewski, David Kavanagh, et al.
Immunobiology|June 9, 2016
Chromosomal rearrangement-A rare cause of complement factor I associated atypical haemolytic uraemic syndromePatrick J Gleeson, Valerie Wilson, Thomas E Cox, et al.
Neuroimage|November 6, 2004
The application of statistical parametric mapping to 123I-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer's disease and Parkinson's diseaseSean J Colloby, John T O'Brien, John D Fenwick, et al.
Molecules (Basel, Switzerland)|July 9, 2022
Lead Isotopic Constraints on the Provenance of Antarctic Dust and Atmospheric Circulation Patterns Prior to the Mid-Brunhes Event (~430 kyr ago)Changhee Han, Laurie J Burn, Paul Vallelonga, et al.
International Journal of Geriatric Psychiatry|July 22, 2006
Cholinesterase inhibitors in advanced Dementia with Lewy bodies: increase or stop?Sanjeet Pakrasi, Alan Thomas, Urs P Mosimann, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 2, 2013
Short latency afferent inhibition: a biomarker for mild cognitive impairment in Parkinson's disease?Alison J Yarnall, Lynn Rochester, Mark R Baker, et al.
Pageof 58